Article
CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
The pharmacogenomics journal - 1 Feb 2016
Maganda B A, Minzi O M S, Ngaimisi E, Kamuhabwa A A R, Aklillu E
Abstract excerpt
We investigated the influence of efavirenz (EFV)- or nevirapine (NVP)-based antiretroviral therapy (ART) on lumefantrine plasma exposure in HIV-malaria-coinfected patients and implication of pharmacogenetic variations. A total of 269 HIV patients with uncomplicated falciparum malaria on NVP-based ART (NVP-arm), EFV-based ART (EFV-arm) or not receiving ART (control-arm) were enrolled and treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.